ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HSV1 ELISA Kits Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-26S16589
Home | Market Reports | Health| Reproductive Health
Global HSV1 ELISA Kits Market Research Report 2024
BUY CHAPTERS

Global HSV1 ELISA Kits Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-26S16589
Report
November 2025
Pages:149
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
MyBioSource
Wuhan Fine Biotech
BosterBio
Demeditec Diagnostics
IBL-America
Biorbyt
Abnova Corporation
United States Biological

HSV1 ELISA Kits Market

The global HSV1 ELISA Kits market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
HSV1 ELISA kits are enzyme-linked immunosorbent assay kits used for the detection and quantification of antibodies specific to Herpes Simplex Virus type 1 (HSV1) in a biological sample. These kits utilize an ELISA method to detect the presence of antibodies produced by the immune system in response to HSV1 infection. This diagnostic tool is commonly used in clinical settings to diagnose HSV1 infections and monitor immune responses in patients. The HSV1 ELISA kits provide a sensitive and reliable method for detecting antibodies against HSV1, aiding in the diagnosis and management of herpes infections.
The industry trend for HSV1 ELISA kits is on the rise due to the increasing prevalence of HSV1 infections globally. With a growing emphasis on early and accurate diagnosis of infectious diseases, there is a rising demand for reliable diagnostic tools like ELISA kits for HSV1. Additionally, advancements in technology have led to the development of more sensitive and specific HSV1 ELISA kits, improving their performance and accuracy. As healthcare systems focus on preventive care and disease management, the market for HSV1 ELISA kits is expected to expand further, catering to the needs of healthcare professionals and patients alike.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global HSV1 ELISA Kits market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of HSV1 ELISA Kits Market Report

Report Metric Details
Report Name HSV1 ELISA Kits Market
Segment by Type
  • IgM
  • IgG
Segment by Application
  • Hospital
  • Laboratory
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company MyBioSource, Wuhan Fine Biotech, BosterBio, DEMEDITEC Diagnostics, IBL- America, Biorbyt, Abnova Corporation, United States Biological
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the HSV1 ELISA Kits study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the HSV1 ELISA Kits Market report?

Ans: The main players in the HSV1 ELISA Kits Market are MyBioSource, Wuhan Fine Biotech, BosterBio, DEMEDITEC Diagnostics, IBL- America, Biorbyt, Abnova Corporation, United States Biological

What are the Application segmentation covered in the HSV1 ELISA Kits Market report?

Ans: The Applications covered in the HSV1 ELISA Kits Market report are Hospital, Laboratory, Others

What are the Type segmentation covered in the HSV1 ELISA Kits Market report?

Ans: The Types covered in the HSV1 ELISA Kits Market report are IgM, IgG

1 Study Coverage
1.1 Introduction to HSV1 ELISA Kits: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global HSV1 ELISA Kits Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 IgM
1.2.3 IgG
1.3 Market Segmentation by Application
1.3.1 Global HSV1 ELISA Kits Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global HSV1 ELISA Kits Revenue Estimates and Forecasts 2020-2031
2.2 Global HSV1 ELISA Kits Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global HSV1 ELISA Kits Sales Estimates and Forecasts 2020-2031
2.4 Global HSV1 ELISA Kits Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global HSV1 ELISA Kits Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global HSV1 ELISA Kits Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 IgM Market Size by Manufacturers
3.5.2 IgG Market Size by Manufacturers
3.6 Global HSV1 ELISA Kits Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global HSV1 ELISA Kits Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global HSV1 ELISA Kits Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global HSV1 ELISA Kits Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global HSV1 ELISA Kits Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America HSV1 ELISA Kits Sales and Revenue by Type (2020-2031)
6.4 North America HSV1 ELISA Kits Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America HSV1 ELISA Kits Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe HSV1 ELISA Kits Sales and Revenue by Type (2020-2031)
7.4 Europe HSV1 ELISA Kits Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe HSV1 ELISA Kits Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific HSV1 ELISA Kits Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific HSV1 ELISA Kits Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific HSV1 ELISA Kits Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America HSV1 ELISA Kits Sales and Revenue by Type (2020-2031)
9.4 Central and South America HSV1 ELISA Kits Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America HSV1 ELISA Kits Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa HSV1 ELISA Kits Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa HSV1 ELISA Kits Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa HSV1 ELISA Kits Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 MyBioSource
11.1.1 MyBioSource Corporation Information
11.1.2 MyBioSource Business Overview
11.1.3 MyBioSource HSV1 ELISA Kits Product Models, Descriptions and Specifications
11.1.4 MyBioSource HSV1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 MyBioSource HSV1 ELISA Kits Sales by Product in 2024
11.1.6 MyBioSource HSV1 ELISA Kits Sales by Application in 2024
11.1.7 MyBioSource HSV1 ELISA Kits Sales by Geographic Area in 2024
11.1.8 MyBioSource HSV1 ELISA Kits SWOT Analysis
11.1.9 MyBioSource Recent Developments
11.2 Wuhan Fine Biotech
11.2.1 Wuhan Fine Biotech Corporation Information
11.2.2 Wuhan Fine Biotech Business Overview
11.2.3 Wuhan Fine Biotech HSV1 ELISA Kits Product Models, Descriptions and Specifications
11.2.4 Wuhan Fine Biotech HSV1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Wuhan Fine Biotech HSV1 ELISA Kits Sales by Product in 2024
11.2.6 Wuhan Fine Biotech HSV1 ELISA Kits Sales by Application in 2024
11.2.7 Wuhan Fine Biotech HSV1 ELISA Kits Sales by Geographic Area in 2024
11.2.8 Wuhan Fine Biotech HSV1 ELISA Kits SWOT Analysis
11.2.9 Wuhan Fine Biotech Recent Developments
11.3 BosterBio
11.3.1 BosterBio Corporation Information
11.3.2 BosterBio Business Overview
11.3.3 BosterBio HSV1 ELISA Kits Product Models, Descriptions and Specifications
11.3.4 BosterBio HSV1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 BosterBio HSV1 ELISA Kits Sales by Product in 2024
11.3.6 BosterBio HSV1 ELISA Kits Sales by Application in 2024
11.3.7 BosterBio HSV1 ELISA Kits Sales by Geographic Area in 2024
11.3.8 BosterBio HSV1 ELISA Kits SWOT Analysis
11.3.9 BosterBio Recent Developments
11.4 DEMEDITEC Diagnostics
11.4.1 DEMEDITEC Diagnostics Corporation Information
11.4.2 DEMEDITEC Diagnostics Business Overview
11.4.3 DEMEDITEC Diagnostics HSV1 ELISA Kits Product Models, Descriptions and Specifications
11.4.4 DEMEDITEC Diagnostics HSV1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 DEMEDITEC Diagnostics HSV1 ELISA Kits Sales by Product in 2024
11.4.6 DEMEDITEC Diagnostics HSV1 ELISA Kits Sales by Application in 2024
11.4.7 DEMEDITEC Diagnostics HSV1 ELISA Kits Sales by Geographic Area in 2024
11.4.8 DEMEDITEC Diagnostics HSV1 ELISA Kits SWOT Analysis
11.4.9 DEMEDITEC Diagnostics Recent Developments
11.5 IBL- America
11.5.1 IBL- America Corporation Information
11.5.2 IBL- America Business Overview
11.5.3 IBL- America HSV1 ELISA Kits Product Models, Descriptions and Specifications
11.5.4 IBL- America HSV1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 IBL- America HSV1 ELISA Kits Sales by Product in 2024
11.5.6 IBL- America HSV1 ELISA Kits Sales by Application in 2024
11.5.7 IBL- America HSV1 ELISA Kits Sales by Geographic Area in 2024
11.5.8 IBL- America HSV1 ELISA Kits SWOT Analysis
11.5.9 IBL- America Recent Developments
11.6 Biorbyt
11.6.1 Biorbyt Corporation Information
11.6.2 Biorbyt Business Overview
11.6.3 Biorbyt HSV1 ELISA Kits Product Models, Descriptions and Specifications
11.6.4 Biorbyt HSV1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Biorbyt Recent Developments
11.7 Abnova Corporation
11.7.1 Abnova Corporation Corporation Information
11.7.2 Abnova Corporation Business Overview
11.7.3 Abnova Corporation HSV1 ELISA Kits Product Models, Descriptions and Specifications
11.7.4 Abnova Corporation HSV1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Abnova Corporation Recent Developments
11.8 United States Biological
11.8.1 United States Biological Corporation Information
11.8.2 United States Biological Business Overview
11.8.3 United States Biological HSV1 ELISA Kits Product Models, Descriptions and Specifications
11.8.4 United States Biological HSV1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 United States Biological Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 HSV1 ELISA Kits Industry Chain
12.2 HSV1 ELISA Kits Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 HSV1 ELISA Kits Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 HSV1 ELISA Kits Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 HSV1 ELISA Kits Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global HSV1 ELISA Kits Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
MyBioSource
Wuhan Fine Biotech
BosterBio
Demeditec Diagnostics
IBL-America
Biorbyt
Abnova Corporation
United States Biological
List of Tables
 Table 1. Global HSV1 ELISA Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global HSV1 ELISA Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global HSV1 ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global HSV1 ELISA Kits Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global HSV1 ELISA Kits Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global HSV1 ELISA Kits Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global HSV1 ELISA Kits Sales by Region (2020-2025) & (K Units)
 Table 8. Global HSV1 ELISA Kits Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global HSV1 ELISA Kits Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global HSV1 ELISA Kits Sales Share by Manufacturers (2020-2025)
 Table 12. Global HSV1 ELISA Kits Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global HSV1 ELISA Kits Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global HSV1 ELISA Kits by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HSV1 ELISA Kits as of 2024)
 Table 16. Global HSV1 ELISA Kits Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global HSV1 ELISA Kits Average Selling Price (ASP) by Manufacturers (2020-2025) & (K US$/Unit)
 Table 18. Key Manufacturers HSV1 ELISA Kits Manufacturing Base and Headquarters
 Table 19. Global HSV1 ELISA Kits Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global HSV1 ELISA Kits Sales by Type (2020-2025) & (K Units)
 Table 23. Global HSV1 ELISA Kits Sales by Type (2026-2031) & (K Units)
 Table 24. Global HSV1 ELISA Kits Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global HSV1 ELISA Kits Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global HSV1 ELISA Kits ASP by Type (2020-2031) & (K US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global HSV1 ELISA Kits Sales by Application (2020-2025) & (K Units)
 Table 29. Global HSV1 ELISA Kits Sales by Application (2026-2031) & (K Units)
 Table 30. HSV1 ELISA Kits High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global HSV1 ELISA Kits Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global HSV1 ELISA Kits Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global HSV1 ELISA Kits ASP by Application (2020-2031) & (K US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America HSV1 ELISA Kits Growth Accelerators and Market Barriers
 Table 37. North America HSV1 ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America HSV1 ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe HSV1 ELISA Kits Growth Accelerators and Market Barriers
 Table 40. Europe HSV1 ELISA Kits Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe HSV1 ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific HSV1 ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific HSV1 ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific HSV1 ELISA Kits Growth Accelerators and Market Barriers
 Table 45. Southeast Asia HSV1 ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America HSV1 ELISA Kits Investment Opportunities and Key Challenges
 Table 47. Central and South America HSV1 ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa HSV1 ELISA Kits Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa HSV1 ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. MyBioSource Corporation Information
 Table 51. MyBioSource Description and Major Businesses
 Table 52. MyBioSource Product Models, Descriptions and Specifications
 Table 53. MyBioSource Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 54. MyBioSource Sales Value Proportion by Product in 2024
 Table 55. MyBioSource Sales Value Proportion by Application in 2024
 Table 56. MyBioSource Sales Value Proportion by Geographic Area in 2024
 Table 57. MyBioSource HSV1 ELISA Kits SWOT Analysis
 Table 58. MyBioSource Recent Developments
 Table 59. Wuhan Fine Biotech Corporation Information
 Table 60. Wuhan Fine Biotech Description and Major Businesses
 Table 61. Wuhan Fine Biotech Product Models, Descriptions and Specifications
 Table 62. Wuhan Fine Biotech Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 63. Wuhan Fine Biotech Sales Value Proportion by Product in 2024
 Table 64. Wuhan Fine Biotech Sales Value Proportion by Application in 2024
 Table 65. Wuhan Fine Biotech Sales Value Proportion by Geographic Area in 2024
 Table 66. Wuhan Fine Biotech HSV1 ELISA Kits SWOT Analysis
 Table 67. Wuhan Fine Biotech Recent Developments
 Table 68. BosterBio Corporation Information
 Table 69. BosterBio Description and Major Businesses
 Table 70. BosterBio Product Models, Descriptions and Specifications
 Table 71. BosterBio Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 72. BosterBio Sales Value Proportion by Product in 2024
 Table 73. BosterBio Sales Value Proportion by Application in 2024
 Table 74. BosterBio Sales Value Proportion by Geographic Area in 2024
 Table 75. BosterBio HSV1 ELISA Kits SWOT Analysis
 Table 76. BosterBio Recent Developments
 Table 77. DEMEDITEC Diagnostics Corporation Information
 Table 78. DEMEDITEC Diagnostics Description and Major Businesses
 Table 79. DEMEDITEC Diagnostics Product Models, Descriptions and Specifications
 Table 80. DEMEDITEC Diagnostics Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 81. DEMEDITEC Diagnostics Sales Value Proportion by Product in 2024
 Table 82. DEMEDITEC Diagnostics Sales Value Proportion by Application in 2024
 Table 83. DEMEDITEC Diagnostics Sales Value Proportion by Geographic Area in 2024
 Table 84. DEMEDITEC Diagnostics HSV1 ELISA Kits SWOT Analysis
 Table 85. DEMEDITEC Diagnostics Recent Developments
 Table 86. IBL- America Corporation Information
 Table 87. IBL- America Description and Major Businesses
 Table 88. IBL- America Product Models, Descriptions and Specifications
 Table 89. IBL- America Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 90. IBL- America Sales Value Proportion by Product in 2024
 Table 91. IBL- America Sales Value Proportion by Application in 2024
 Table 92. IBL- America Sales Value Proportion by Geographic Area in 2024
 Table 93. IBL- America HSV1 ELISA Kits SWOT Analysis
 Table 94. IBL- America Recent Developments
 Table 95. Biorbyt Corporation Information
 Table 96. Biorbyt Description and Major Businesses
 Table 97. Biorbyt Product Models, Descriptions and Specifications
 Table 98. Biorbyt Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 99. Biorbyt Recent Developments
 Table 100. Abnova Corporation Corporation Information
 Table 101. Abnova Corporation Description and Major Businesses
 Table 102. Abnova Corporation Product Models, Descriptions and Specifications
 Table 103. Abnova Corporation Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 104. Abnova Corporation Recent Developments
 Table 105. United States Biological Corporation Information
 Table 106. United States Biological Description and Major Businesses
 Table 107. United States Biological Product Models, Descriptions and Specifications
 Table 108. United States Biological Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 109. United States Biological Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. HSV1 ELISA Kits Product Picture
 Figure 2. Global HSV1 ELISA Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. IgM Product Picture
 Figure 4. IgG Product Picture
 Figure 5. Global HSV1 ELISA Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Laboratory
 Figure 8. Others
 Figure 9. HSV1 ELISA Kits Report Years Considered
 Figure 10. Global HSV1 ELISA Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global HSV1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 12. Global HSV1 ELISA Kits Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global HSV1 ELISA Kits Revenue Market Share by Region (2020-2031)
 Figure 14. Global HSV1 ELISA Kits Sales (2020-2031) & (K Units)
 Figure 15. Global HSV1 ELISA Kits Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global HSV1 ELISA Kits Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers HSV1 ELISA Kits Sales Volume Market Share in 2024
 Figure 18. Global HSV1 ELISA Kits Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. IgM Revenue Market Share by Manufacturer in 2024
 Figure 21. IgG Revenue Market Share by Manufacturer in 2024
 Figure 22. Global HSV1 ELISA Kits Sales Market Share by Type (2020-2031)
 Figure 23. Global HSV1 ELISA Kits Revenue Market Share by Type (2020-2031)
 Figure 24. Global HSV1 ELISA Kits Sales Market Share by Application (2020-2031)
 Figure 25. Global HSV1 ELISA Kits Revenue Market Share by Application (2020-2031)
 Figure 26. North America HSV1 ELISA Kits Sales YoY (2020-2031) & (K Units)
 Figure 27. North America HSV1 ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers HSV1 ELISA Kits Sales Revenue (US$ Million) in 2024
 Figure 29. North America HSV1 ELISA Kits Sales Volume (K Units) by Type (2020- 2031)
 Figure 30. North America HSV1 ELISA Kits Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America HSV1 ELISA Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 32. North America HSV1 ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US HSV1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada HSV1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico HSV1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe HSV1 ELISA Kits Sales YoY (2020-2031) & (K Units)
 Figure 37. Europe HSV1 ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers HSV1 ELISA Kits Sales Revenue (US$ Million) in 2024
 Figure 39. Europe HSV1 ELISA Kits Sales Volume (K Units) by Type (2020-2031)
 Figure 40. Europe HSV1 ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe HSV1 ELISA Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 42. Europe HSV1 ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany HSV1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 44. France HSV1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. HSV1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy HSV1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia HSV1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific HSV1 ELISA Kits Sales YoY (2020-2031) & (K Units)
 Figure 49. Asia-Pacific HSV1 ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers HSV1 ELISA Kits Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific HSV1 ELISA Kits Sales Volume (K Units) by Type (2020- 2031)
 Figure 52. Asia-Pacific HSV1 ELISA Kits Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific HSV1 ELISA Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 54. Asia-Pacific HSV1 ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia HSV1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan HSV1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea HSV1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan HSV1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 59. India HSV1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America HSV1 ELISA Kits Sales YoY (2020-2031) & (K Units)
 Figure 61. Central and South America HSV1 ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers HSV1 ELISA Kits Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America HSV1 ELISA Kits Sales Volume (K Units) by Type (2021-2031)
 Figure 64. Central and South America HSV1 ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America HSV1 ELISA Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 66. Central and South America HSV1 ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil HSV1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina HSV1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa HSV1 ELISA Kits Sales YoY (2020-2031) & (K Units)
 Figure 70. Middle East and Africa HSV1 ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers HSV1 ELISA Kits Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa HSV1 ELISA Kits Sales Volume (K Units) by Type (2021-2031)
 Figure 73. South America HSV1 ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa HSV1 ELISA Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 75. Middle East and Africa HSV1 ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries HSV1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey HSV1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt HSV1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa HSV1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 80. HSV1 ELISA Kits Industry Chain Mapping
 Figure 81. Regional HSV1 ELISA Kits Manufacturing Base Distribution (%)
 Figure 82. Global HSV1 ELISA Kits Production Market Share by Region (2020-2031)
 Figure 83. HSV1 ELISA Kits Production Process
 Figure 84. Regional HSV1 ELISA Kits Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Human Anti Herpes Simplex Virus Type 1 ELISA Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HIV 1 ELISA Kits Market Research Report 2024
Global Infectious Disease Detection ELISA Kits Market Research Report 2024
Global Chlamydia ELISA Kits Market Research Report 2024
Global Norovirus ELISA Kits Market Research Report 2024
Global CMV ELISA Kits Market Research Report 2024
Global H1N1 ELISA Kits Market Research Report 2024
Global HMGB1 ELISA Kit Market Research Report 2024
Global Herpes Simplex Virus Testing Kits Market Research Report 2024
Global Dengue NS1 ELISA Kits Market Research Report 2024
Global Herpes Testing Kits Market Research Report 2024
Global CXCR1 ELISA Kit Market Research Report 2024
Global Mycoplasma ELISA Kits Market Research Report 2024
Global Cytomegalovirus ELISA Kits Market Research Report 2024
Global Immunology Oncology Elisa Kits Market Research Report 2024
Global IFN Gamma ELISA Kit Market Research Report 2024
Global Nuclease ELISA Kit Market Research Report 2024
Global Hantavirus ELISA Kit Market Research Report 2024
Global IgM ELISA Kit Market Research Report 2024
Global Enterovirus ELISA Kits Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions